Inhibiting FAK–Paxillin Interaction Reduces Migration and Invadopodia-Mediated Matrix Degradation in Metastatic Melanoma Cells
The nonreceptor tyrosine kinase FAK is a promising target for solid tumor treatment because it promotes invasion, tumor progression, and drug resistance when overexpressed. Investigating the role of FAK in human melanoma cells, we found that both in situ and metastatic melanoma cells strongly expres...
Main Authors: | Antoine Mousson, Marlène Legrand, Tania Steffan, Romain Vauchelles, Philippe Carl, Jean-Pierre Gies, Maxime Lehmann, Guy Zuber, Jan De Mey, Denis Dujardin, Emilie Sick, Philippe Rondé |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1871 |
Similar Items
-
Arctigenin hinders the invasion and metastasis of cervical cancer cells via the FAK/paxillin pathway
by: Dan Liao, et al.
Published: (2023-06-01) -
Quercetin inhibits LPS-induced macrophage migration by suppressing the iNOS/FAK/paxillin pathway and modulating the cytoskeleton
by: Shuna Cui, et al.
Published: (2019-01-01) -
EB1 Restricts Breast Cancer Cell Invadopodia Formation and Matrix Proteolysis via FAK
by: Brice Chanez, et al.
Published: (2021-02-01) -
Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
by: Antoine Mousson, et al.
Published: (2018-08-01) -
Cytosolic phospholipase A2α modulates cell-matrix adhesion <i>via</i> the FAK/paxillin pathway in hepatocellular carcinoma
by: Piao Guo, et al.
Published: (2019-06-01)